We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Influences of "Fat Controller” Protein Discovered

By Biotechdaily staff writers
Posted on 03 Aug 2006
Scottish researchers have uncovered key links between cystic fibrosis (CF) and cancer, diabetes, and obesity, findings that may lead to new areas of research and new treatments.

The latest research centers on the role in the body of a newly discovered hybrid protein called the cellular "fat controller,” according to Dr. More...
Anil Mehta, of the University of Dundee (Scotland). Dr. Mehta has worked in cystic fibrosis research for 20 years, and heads the European Union-funded Cystic Fibrosis Database based at the University of Dundee. Dr. Mehta and his team have uncovered genetic pathways that lead through this fat controller and form links between cystic fibrosis and the other conditions.

It has long been known that cystic fibrosis patients suffer significant variations in weight--they tend to be very thin and can suffer very fast weight loss when they fall ill--but we did not know why this was the case, said Dr. Mehta, a Reader in Child Health in the Department of Maternal and Child Health Sciences at the University of Dundee.

Similarly it has been known that CF patients suffer a higher rate of cancer than normal and again we did not know why. In equal measure, almost half of these patients develop an unusual form of diabetes. What our research has uncovered are the genetic links, through this cellular fat controller, that we believe lead to these differences in fat metabolism and cancer. Furthermore, there are also significant links here to diabetes.

Dr. Mehta's team examined the relationship between three cancer-related enzymes that are associated with diabetes (NDPK), fat metabolism (AMPK) and cystic fibrosis (CFTR). They found a new pathway between NDPK and AMPK that leads to variations in fat metabolism. Additional research found that these enzymes also bind to a protein that causes cystic fibrosis. The research team included international collaborators in Italy, Germany, France, Portugal, and the United States. The findings were reported in the August 2006 issue of Molecular & Cellular Biology.

In order to further debate and create greater cross-disciplinary collaboration in this area of research, Dundee University has agreed to support Dr. Mehta's efforts to host a major international conference of experts in NDPK, AMPK and CFTR in Dundee in September 2007.



Related Links:
University of Dundee

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automated Clinical Chemistry Analyzer
Envoy 500+
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.